ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

EWTX Edgewise Therapeutics Inc

16,18
-1,19 (-6,85%)
18 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Edgewise Therapeutics Inc EWTX NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-1,19 -6,85% 16,18 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
17,27 15,87 17,27 16,18 17,37
mais cotações »

Notícias Recentes

Data Hora Fonte Título
10/05/202409:00BWEdgewise Therapeutics to Present at the RBC Capital Markets..
09/05/202409:00BWEdgewise Therapeutics Reports First Quarter 2024 Financial..
07/05/202409:00BWEdgewise Therapeutics Appoints Arlene Morris to its Board of..
06/05/202409:00BWEdgewise Therapeutics Doses First Patient in Phase 2..
23/04/202409:00BWEdgewise Receives European Medicines Agency (EMA) Orphan..
15/04/202417:05BWEdgewise Therapeutics Announces Positive Two-Year Topline..
28/03/202409:00BWEdgewise Therapeutics Announces Upcoming Podium Presentation..
27/03/202409:00BWEdgewise Therapeutics to Present at the Cantor Virtual..
05/03/202410:00BWEdgewise Therapeutics to Present at the Leerink Partners..
28/02/202410:00BWEdgewise Therapeutics to Present on EDG-5506 for the..
22/02/202410:00BWEdgewise Therapeutics Reports Fourth Quarter and Full Year..
13/02/202410:00BWEdgewise Receives U.S. FDA Fast Track Designation for..
19/01/202410:37BWEdgewise Therapeutics Announces Pricing of $240 Million..
09/01/202410:39BWEdgewise Therapeutics Highlights 2023 Accomplishments and..
19/12/202310:00BWEdgewise Therapeutics to Present at the 42nd Annual J.P...
18/12/202310:00BWEdgewise Therapeutics Launches First of Its Kind Educational..
30/11/202310:56DJNEdgewise Gets FDA Orphan, Rare-Pediatric-Disease..
30/11/202310:00BWEdgewise Receives Orphan Drug and Rare Pediatric Disease..
09/11/202310:00BWEdgewise Therapeutics Reports Third Quarter 2023 Financial..
08/11/202310:00BWEdgewise Therapeutics to Present at Upcoming Investor..
01/11/202309:00BWEdgewise to Present Data on EDG-7500 at the American Heart..
26/10/202309:00BWEdgewise Therapeutics Announces Expansion of their EDG-5506..
27/09/202309:00BWEdgewise Therapeutics to Present on EDG-5506 for Becker..
26/09/202309:00BWEdgewise Therapeutics Announces Initiation of GRAND CANYON,..
14/09/202309:00BWEdgewise Therapeutics Begins Dosing First-in-Human Phase 1..
10/08/202309:00BWEdgewise Therapeutics Reports Second Quarter 2023 Financial..
26/06/202317:01BWEdgewise Therapeutics Announces Positive 12-Month Topline..